Follow
Tyler Reich
Tyler Reich
University of Wisconsin School of Medicine and Public Health
Verified email at wisc.edu - Homepage
Title
Cited by
Cited by
Year
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
JA Fraietta, CL Nobles, MA Sammons, S Lundh, SA Carty, TJ Reich, ...
Nature 558 (7709), 307-312, 2018
6942018
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
M Ruella, J Xu, DM Barrett, JA Fraietta, TJ Reich, DE Ambrose, ...
Nature medicine 24 (10), 1499-1503, 2018
5422018
BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia
W Kong, A Dimitri, W Wang, IY Jung, CJ Ott, M Fasolino, Y Wang, ...
The Journal of clinical investigation 131 (16), 1-16, 2021
532021
Cars in leukemia: relapse with antigen-negative leukemia originating from a single B cell expressing the leukemia-targeting CAR
SF Lacey, J Xu, M Ruella, DM Barrett, I Kulikovskaya, DE Ambrose, ...
Blood 128 (22), 281, 2016
202016
Lymphocyte lineage-specific and developmental stage specific mechanisms suppress cyclin D3 expression in response to DNA double strand breaks
A DeMicco, T Reich, R Arya, A Rivera-Reyes, MR Fisher, CH Bassing
Cell Cycle 15 (21), 2882-2894, 2016
132016
Clinical Evidence That Deficiency of the Methylcytosine Dioxygenase TET2 Gene Promotes the Clonal Expansion and Therapeutic Efficacy of CD19-Directed T Cells
JA Fraietta, CL Nobles, MA Sammons, SA Carty, SM Lundh, T Reich, ...
Blood 130, 1909, 2017
22017
A goldilocks amount of H3K27me3
TJ Reich, PW Lewis
Nature Chemical Biology 19 (9), 1046-1047, 2023
2023
CARs in Leukemia
J Xu, M Ruella, DM Barrett, I Kulikovskaya, D Ambrose, P Patel, T Reich, ...
MOLECULAR THERAPY 25 (5), 27-27, 2017
2017
Comparative Efficacy of CD19 Chimeric Antigen Receptor T Cells Expressed Using Gamma-Retroviral Vector or Lentiviral Vector
J Scholler, D Barrett, T Chen, T Reich, E Pequignoti, I Kulikovskaya, T Da, ...
MOLECULAR THERAPY 25 (5), 56-56, 2017
2017
TET2 Gene Disruption via Lentiviral Integration Promotes CAR T Cell Expansion and Persistence
JA Fraietta, CL Nobles, M Sammons, S Lundh, SA Carty, T Reich, ...
MOLECULAR THERAPY 25 (5), 332-332, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–10